Hagen Blaszyk
- Surgery top 2%
- Molecular Biology top 5%
- Oncology top 2%
- Gastroenterology top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Arndt HartmannWolfgang DietmaierFerdinand HofstaedterGary M. MaweDavid R. LindenKeith A. SharkeySteve S. SommerMatthew Coates
- Topics
- Cancer-related Molecular Pathways (17 papers)Genetic factors in colorectal cancer (17 papers)Cancer Genomics and Diagnostics (14 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Hagen Blaszyk
89 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Surgery 1.3k
- Molecular Biology 1.3k
- Oncology 1.2k
- Gastroenterology 921
- Pulmonary and Respiratory Medicine 675
Countries citing papers authored by Hagen Blaszyk
This map shows the geographic impact of Hagen Blaszyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hagen Blaszyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hagen Blaszyk more than expected).
Fields of papers citing papers by Hagen Blaszyk
This network shows the impact of papers produced by Hagen Blaszyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hagen Blaszyk. The network helps show where Hagen Blaszyk may publish in the future.
Co-authorship network of co-authors of Hagen Blaszyk
This figure shows the co-authorship network connecting the top 25 collaborators of Hagen Blaszyk. A scholar is included among the top collaborators of Hagen Blaszyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hagen Blaszyk. Hagen Blaszyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 18 | |
| 3 | 123 | |
| 4 | 35 | |
| 5 | 65 | |
| 6 | 260 | |
| 7 | 39 | |
| 8 | 25 | |
| 9 | 16 | |
| 10 | 42 | |
| 11 | 22 | |
| 12 | 80 | |
| 13 | 31 | |
| 14 | 44 | |
| 15 | 36 | |
| 16 | 110 | |
| 17 | 56 | |
| 18 | 21 | |
| 19 | 24 | |
| 20 | P53 gene mutations in breast cancers in Midwestern U.S. women: Null as well as missense-type mutations are associated with poor prognosis | 27 |
About Hagen Blaszyk
Hagen Blaszyk is a scholar working on Oncology, Cancer Research and Microbiology, having authored 90 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), Genetic factors in colorectal cancer (17 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Gastroenterology (921 citations), Cancer Research (667 citations) and Oncology (1.2k citations). Hagen Blaszyk has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Arndt Hartmann, Arndt Hartmann, Wolfgang Dietmaier, Ferdinand Hofstaedter, Gary M. Mawe, David R. Linden, Keith A. Sharkey, Steve S. Sommer, Matthew Coates and Peter J. Wild. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.